Articles

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE
Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB
Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB
Northern Institute for Research, Newcastle University, Newcastle upon Tyne, England
Diamantina Institute, University of Queensland, QLD
Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE
Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Department of Pathology, University of Massachusetts Medical School, UMass Memorial Medical Center, Worcester, MA
Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Diamantina Institute, University of Queensland, QLD
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB
Department of Pathology, Brigham and Womens Hospital, Boston, MA
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB
Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX
Haematologica Early view Apr 1, 2021 https://doi.org/10.3324/haematol.2020.274258